Jianjun Han

1.6k total citations
61 papers, 936 citations indexed

About

Jianjun Han is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jianjun Han has authored 61 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Jianjun Han's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Liver Disease Diagnosis and Treatment (7 papers). Jianjun Han is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Liver Disease Diagnosis and Treatment (7 papers). Jianjun Han collaborates with scholars based in China, United States and South Korea. Jianjun Han's co-authors include Zengjun Li, Yanlai Sun, Chunxiao Zhou, Victoria Bae‐Jump, Hui Guo, Weiya Z. Wysham, Xiugui Sheng, Dario R. Roque, Huirong Xu and Lu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jianjun Han

59 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjun Han China 16 405 281 275 175 128 61 936
Yuanfeng Gong China 18 475 1.2× 317 1.1× 321 1.2× 223 1.3× 129 1.0× 50 1.0k
Yoshifumi Morita Japan 16 406 1.0× 257 0.9× 279 1.0× 292 1.7× 268 2.1× 83 1.1k
Binbin Du China 18 370 0.9× 199 0.7× 204 0.7× 203 1.2× 128 1.0× 49 898
Yuko Sugiyama Japan 14 244 0.6× 346 1.2× 153 0.6× 195 1.1× 127 1.0× 62 968
Dinghua Yang China 16 485 1.2× 398 1.4× 387 1.4× 109 0.6× 191 1.5× 41 1000
Panagiotis Sarantis Greece 19 503 1.2× 476 1.7× 247 0.9× 157 0.9× 139 1.1× 75 1.1k
Yuichiro Yokoyama Japan 15 348 0.9× 287 1.0× 152 0.6× 250 1.4× 95 0.7× 89 937
Megumi Baba Japan 19 395 1.0× 294 1.0× 224 0.8× 167 1.0× 197 1.5× 48 977
Frederik J.H. Hoogwater Netherlands 17 296 0.7× 369 1.3× 118 0.4× 278 1.6× 136 1.1× 54 843

Countries citing papers authored by Jianjun Han

Since Specialization
Citations

This map shows the geographic impact of Jianjun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Han more than expected).

Fields of papers citing papers by Jianjun Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Han. The network helps show where Jianjun Han may publish in the future.

Co-authorship network of co-authors of Jianjun Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Han. A scholar is included among the top collaborators of Jianjun Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Han. Jianjun Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hao, Xuewen Gong, Yuanmin Li, et al.. (2025). Multiomics reveals metformin’s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention. Scientific Reports. 15(1). 22699–22699.
2.
Geng, Cuizhi, Yueping Liu, Jianjun Han, et al.. (2024). A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02.. Journal of Clinical Oncology. 42(16_suppl). TPS626–TPS626. 1 indexed citations
3.
Zhang, Hao, et al.. (2024). Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(2). 189086–189086. 10 indexed citations
4.
Chen, Miao‐Ling, Jianbo Zhang, Hao Zhang, et al.. (2022). Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes. Frontiers in Endocrinology. 13. 996228–996228. 8 indexed citations
5.
6.
Zhang, Hao, Chunxue Wu, Miao‐Ling Chen, et al.. (2021). Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1. BMC Cancer. 21(1). 1063–1063. 5 indexed citations
7.
Zhang, Hao, Chunxue Wu, Jianbo Zhang, et al.. (2020). HMGB1, the Next Predictor of Transcatheter Arterial Chemoembolization for Liver Metastasis of Colorectal Cancer?. Frontiers in Oncology. 10. 572418–572418. 5 indexed citations
8.
9.
Wang, Dongyang, Jianjun Zhang, Zengjun Li, et al.. (2018). Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma. Digestive Diseases. 37(3). 214–225. 11 indexed citations
10.
Wysham, Weiya Z., Dario R. Roque, Jianjun Han, et al.. (2016). Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines. Targeted Oncology. 11(6). 763–769. 33 indexed citations
11.
12.
Li, Zengjun, et al.. (2016). Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer. Oncology Reports. 35(3). 1403–1408. 23 indexed citations
13.
Sun, Yanlai, Huirong Xu, Zengjun Li, et al.. (2016). Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis. World Journal of Surgical Oncology. 14(1). 61–61. 99 indexed citations
14.
Zhang, Lu, Jianjun Han, Amanda Jackson, et al.. (2016). NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo. Journal of Hematology & Oncology. 9(1). 91–91. 17 indexed citations
15.
Li, Zengjun, Haipeng Wang, Yanlai Sun, et al.. (2015). Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis. OncoTargets and Therapy. 8. 3523–3523. 14 indexed citations
16.
Han, Jianjun, et al.. (2015). Induction of Apoptosis by IGFBP3 Overexpression in Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 15(23). 10085–10089. 14 indexed citations
17.
Zhang, Lu, Jianjun Han, Xiaohong Liang, et al.. (2014). The Association of HMGB1 Expression with Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review. PLoS ONE. 9(10). e110626–e110626. 30 indexed citations
18.
Liu, Li, Gang Wu, Fang Xue, et al.. (2013). Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers. European Journal of Cancer. 49(9). 2143–2151. 27 indexed citations
19.
Du, Juan, Lei Wang, Jianjun Han, et al.. (2012). Serum soluble death receptor 5 concentration in patients with chronic hepatitis B is associated with liver damage and viral antigen level. Clinical Biochemistry. 45(10-11). 845–847. 4 indexed citations
20.
Zhang, Fujun, et al.. (2011). On the In Vivo Degradation Performance of Stranded 125I Seeds Connected With AZ31B Magnesium Alloy. Brachytherapy. 10. S98–S98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanfeng Gong Breakdown of academic impact, for papers by Yoshifumi Morita Breakdown of academic impact, for papers by Binbin Du Breakdown of academic impact, for papers by Yuko Sugiyama Breakdown of academic impact, for papers by Dinghua Yang Breakdown of academic impact, for papers by Panagiotis Sarantis Breakdown of academic impact, for papers by Yuichiro Yokoyama Breakdown of academic impact, for papers by Megumi Baba Breakdown of academic impact, for papers by Frederik J.H. Hoogwater
Rankless by CCL
2026